United States · News · New York Post

‘Triple-G’ weight loss drug update: Even on the lowest dose, trial patients lost 12.7% of their weight

Published by New York Post · United States 3 h ago

The drug, the first of its kind to target three metabolic receptors (GLP-1, GIP, and glucagon), is nearing the end of clinical trials and is expected to be submitted to the FDA…

Read the full article on New York Post Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (nypost.com)

Also worth reading

NYT Climate

Climate Forward Highlights: Energy Secretary Dismisses Idea of Diesel Export Ban

Mongabay

Gabon, home to the medicinal plant behind ibogaine, wants a fairer share of its global boom

The Hill

House Democrats call for GAO to investigate government-funded Trump ads

CBS News

Trump renews threat to resume attacks on Iran after U.S. midterms

NPR

What a Pearly King taught me about Cockney rhyming slang and East London history

PBS NewsHour